Development of new therapeutic strategies for mesothelioma
- 31 March 1993
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 9 (1-6) , 413-417
- https://doi.org/10.1016/0169-5002(93)90700-8
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- HLA Antigen Expression and Malignant MesotheliomaAmerican Journal of Respiratory Cell and Molecular Biology, 1991
- Interaction between dactinomycin and tumor necrosis factor in mesothelioma. Cachexia without oncoiysisCancer, 1991
- Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusionsInternational Journal of Cancer, 1991
- Asbestos fibres inhibit the in vitro activity of ymphokine-activated killer (LAK) cells from healthy individualsand patients with malignant mesotheliomaClinical and Experimental Immunology, 1991
- Indomethacin augments lymphokine-activated killer cell generation by patients with malignant mesotheliomaClinical Immunology and Immunopathology, 1989
- Lysis of Human Malignant Mesothelioma Cells by Natural Killer (NK) and Lymphokine-activated Killer (LAK) CellsAmerican Review of Respiratory Disease, 1989
- Asbestos and Cancer: Human Natural Killer Cell Activity is Suppressed by Asbestos Fibers but Can Be Restored by Recombinant lnterleukin-2American Review of Respiratory Disease, 1989